secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2022-07-21T23:59:59+00:00
Accession:  0001193125-22-199173
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences enters new $750M five-year revolving credit facility, replaces 2018 agreement
--------------------------------------------------------------------------------

- New $750M unsecured multi-currency revolving credit facility matures July 15, 2027.
- Pricing improved vs. 2018 facility; margin tied to leverage ratio or debt ratings.
- Facility includes options for increase up to $250M additional and multicurrency sub-limits.
- No amounts drawn as of July 15, 2022; proceeds for general corporate purposes and refinancing.
- Terminated the existing 2018 credit agreement on same date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000119312522199173/0001193125-22-199173-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000119312522199173/d383535d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-199173

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer